Copyright
©The Author(s) 2016.
World J Respirol. Jul 28, 2016; 6(2): 57-62
Published online Jul 28, 2016. doi: 10.5320/wjr.v6.i2.57
Published online Jul 28, 2016. doi: 10.5320/wjr.v6.i2.57
Figure 2 Lung cancer resistance: Model showing how tumor may acquire stronger clones after first treatment, leading to predominant second sub-clones, demonstrating the tumor heterogeneity.
- Citation: Macedo JE. New era of epidermal growth factor receptor-tyrosine kinase inhibitors for lung cancer. World J Respirol 2016; 6(2): 57-62
- URL: https://www.wjgnet.com/2218-6255/full/v6/i2/57.htm
- DOI: https://dx.doi.org/10.5320/wjr.v6.i2.57